Propel Bio Management, LLC
29 holdingsFiling period: 2026-06-30Current AUM: $193.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HOLDINGS LP-CL | 1.27M | $30.9M | $35.4M | 18.29% | -- | 2026-06-30 |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | 4.03M | $26.3M | $29.5M | 15.25% | +247.6K | 2026-06-30 |
| 3 | CORT | CORCEPT THERAPEUTICS INC | 136.5K | $11.9M | $15.1M | 7.81% | -11,329 | 2026-06-30 |
| 4 | PHAT | PHATHOM PHARMACEUTICALS I | 1.05M | $11.4M | $8.6M | 4.43% | +209.1K | 2026-06-30 |
| 5 | DCTH | DELCATH SYSTEMS INC | 871.5K | $11.0M | $14.1M | 7.28% | -108,238 | 2026-06-30 |
| 6 | MIST | MILESTONE PHARMACEUTICALS | 7.43M | $10.0M | $6.9M | 3.56% | +3.31M | 2026-06-30 |
| 7 | CMPS | COMPASS PATHWAYS PLC | 573.1K | $8.1M | $7.9M | 4.09% | -168,963 | 2026-06-30 |
| 8 | KYTX | KYVERNA THERAPEUTICS INC | 883.2K | $7.9M | $6.1M | 3.17% | +238.8K | 2026-06-30 |
| 9 | ARTV | ARTIVA BIOTHERAPEUTICS IN | 696.4K | $6.8M | $6.2M | 3.20% | +550.1K | 2026-06-30 |
| 10 | ABEO | ABEONA THERAPEUTICS INC | 983.1K | $6.1M | $5.4M | 2.78% | -346,829 | 2026-06-30 |
| 11 | AQST | AQUESTIVE THERAPEUTICS IN | 1.44M | $6.0M | $6.9M | 3.58% | +731.4K | 2026-06-30 |
| 12 | PALI | PALISADE BIO INC | 2.58M | $5.4M | $5.2M | 2.69% | +1.47M | 2026-06-30 |
| 13 | IMUX | IMMUNIC INC | 325.0K | $5.0M | $3.4M | 1.74% | -- | 2026-06-30 |
| 14 | IVA | INVENTIVA SA - ADR | 1.28M | $4.8M | $4.9M | 2.55% | +556.5K | 2026-06-30 |
| 15 | SABS | SAB BIOTHERAPEUTICS INC | 1.08M | $4.2M | $3.7M | 1.90% | +63.8K | 2026-06-30 |
| 16 | OBIO | ORCHESTRA BIOMED HOLDINGS | 896.7K | $3.9M | $5.4M | 2.80% | -- | 2026-06-30 |
| 17 | CLDX | CELLDEX THERAPEUTICS INC | 103.7K | $3.9M | $4.0M | 2.06% | -27,669 | 2026-06-30 |
| 18 | ZVRA | ZEVRA THERAPEUTICS INC | 253.5K | $3.6M | $3.0M | 1.53% | -28,874 | 2026-06-30 |
| 19 | OCUL | OCULAR THERAPEUTIX INC | 358.0K | $3.5M | $3.6M | 1.88% | -24,409 | 2026-06-30 |
| 20 | FDMT | 4D MOLECULAR THERAPEUTICS IN | 252.7K | $3.4M | $3.4M | 1.78% | -127,766 | 2026-06-30 |
| 21 | OVID | OVID THERAPEUTICS INC | 1.12M | $3.0M | $3.0M | 1.56% | +194.1K | 2026-06-30 |
| 22 | EYPT | EYEPOINT INC | 191.7K | $2.7M | $702K | 0.36% | -24,080 | 2026-06-30 |
| 23 | UPB | UPSTREAM BIO INC | 350.4K | $2.4M | $1.9M | 0.99% | +8.6K | 2026-06-30 |
| 24 | SCYX | SCYNEXIS INC | 543.5K | $2.2M | $2.4M | 1.23% | -- | 2026-06-30 |
| 25 | SLN | SILENCE THERAPEUTICS PLC | 191.7K | $2.1M | $2.4M | 1.23% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2